These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 455298)
1. Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat. Becci PJ; Thompson HJ; Grubbs CJ; Brown CC; Moon RC Cancer Res; 1979 Aug; 39(8):3141-4. PubMed ID: 455298 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631 [TBL] [Abstract][Full Text] [Related]
3. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice. Thompson HJ; Becci PJ; Grubbs CJ; Shealy YF; Stanek EJ; Brown CC; Sporn MB; Moon RC Cancer Res; 1981 Mar; 41(3):933-6. PubMed ID: 7459880 [TBL] [Abstract][Full Text] [Related]
5. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Becci PJ; Thompson HJ; Strum JM; Brown CC; Sporn MB; Moon RC Cancer Res; 1981 Mar; 41(3):927-32. PubMed ID: 7459879 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors. Grubbs CJ; Juliana MM; Eto I; Casebolt T; Whitaker LM; Canfield GJ; Manczak M; Steele VE; Kelloff GJ Anticancer Res; 1993; 13(1):33-6. PubMed ID: 8476227 [TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Miyata Y; Tsuda H; Matayoshi-Miyasato K; Fukushima S; Murasaki G; Ogiso T; Ito N Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis. Uchida K; Seidenfeld J; Rademaker A; Oyasu R Cancer Res; 1989 Oct; 49(19):5249-53. PubMed ID: 2504487 [TBL] [Abstract][Full Text] [Related]
9. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Kitahori Y; Konishi N; Shimoyama T; Hiasa Y Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of N-n-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in rats by administration of disulfiram in the diet. Irving CC; Tice AJ; Murphy WM Cancer Res; 1979 Aug; 39(8):3040-3. PubMed ID: 455288 [TBL] [Abstract][Full Text] [Related]
11. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236 [TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295 [TBL] [Abstract][Full Text] [Related]
13. 13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat. Sporn MB; Squire RA; Brown CC; Smith JM; Wenk ML; Springer S Science; 1977 Feb; 195(4277):487-9. PubMed ID: 835006 [TBL] [Abstract][Full Text] [Related]
14. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102 [TBL] [Abstract][Full Text] [Related]
15. Histopathological evaluation of the inhibition of rat bladder carcinogenesis by 13-cis-retinoic acid. Squire RA; Sporn MB; Brown CC; Smith JM; Wenk ML; Springer S Cancer Res; 1977 Aug; 37(8 Pt 2):2930-6. PubMed ID: 872122 [TBL] [Abstract][Full Text] [Related]
16. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine. Becci PJ; Thompson HJ; Grubbs CJ; Moon RC J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573 [No Abstract] [Full Text] [Related]
17. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
19. [A model of rat's urinary bladder tumor induced by subcutaneous injection of N-butyl-N-(4-hydroxybutyl)-nitrosamine]. Pliss GB; Vlasov NN; Iogannsen MG; Frolov AG Vopr Onkol; 1998; 44(4):432-5. PubMed ID: 9807207 [TBL] [Abstract][Full Text] [Related]
20. Lack of enhancing effect of mucosal regeneration following ulceration of the urinary bladder on N-butyl-N-(4-hydroxybutyl)nitrosamine carcinogenesis in rats. Shirai T Cancer Res; 1980 Oct; 40(10):3709-12. PubMed ID: 7438054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]